C. Brittain

Conducting a randomised trial during an influenza pandemic: an example of a trial set up and ‘hibernated’ ready to activate and recruit within 4 weeks

W. Lim, L. Duley, G. Meakin, 2015, Trials.

Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial 'in hibernation', ready for rapid activation.

W. Lim, A. Montgomery, D. Whynes, 2015, Health technology assessment.

Lactic acid gel versus metronidazole for recurrent bacterial vaginosis in women aged 16 years and over: the VITA RCT.

J. Kai, L. Armstrong-Buisseret, J. Daniels, 2022, Health technology assessment.

Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial

Louise J Jackson, A. Montgomery, T. Roberts, 2019, The Lancet.

Acceptability of and treatment preferences for recurrent bacterial vaginosis—Topical lactic acid gel or oral metronidazole antibiotic: Qualitative findings from the VITA trial

J. Kai, J. Anstey Watkins, Frances Griffiths, 2019, PloS one.

Gentamicin as an alternative to ceftriaxone in the treatment of gonorrhoea: the G-TOG non-inferiority RCT.

Louise J Jackson, A. Montgomery, T. Roberts, 2019, Health technology assessment.

Improving readiness for recruitment through simulated trial activation: the Adjuvant Steroids in Adults with Pandemic influenza (ASAP) trial

W. Lim, L. Duley, G. Meakin, 2017, Trials.

Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomised controlled trial

L. Armstrong-Buisseret, Frances Griffiths, T. Hepburn, 2023, BMC Women's Health.